| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6531141 | VALEANT PHARMS NORTH | Oil-in-water emulsion containing tretinoin |
Mar, 2020
(4 years ago) | |
Renova is owned by Valeant Pharms North.
Renova contains Tretinoin.
Renova has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Renova are:
- US6531141
Renova was authorised for market use on 31 August, 2000.
Renova is available in cream;topical dosage forms.
The generics of Renova are possible to be released after 07 March, 2020.
Drugs and Companies using TRETINOIN ingredient
Market Authorisation Date: 31 August, 2000
Treatment: NA
Dosage: CREAM;TOPICAL
More Information on Dosage
RENOVA family patents
